Skip to main content
Skip to footer
Opens in a new tab
Search
Home
About UK NEQAS
Our Team
Sustainability
EQA/PT Programmes
Trial Schedules
Programme Flyers
New Participant Information
Publications
Flow Cytometry Programmes
Molecular Haemato-oncology Programmes
News
FAQs
Contact Us
Home
About UK NEQAS
Our Team
Sustainability
EQA/PT Programmes
Trial Schedules
Programme Flyers
New Participant Information
Publications
Flow Cytometry Programmes
Molecular Haemato-oncology Programmes
News
FAQs
Contact Us
Home
|
UK recommendations for chimerism testing and monitoring following allogeneic haematopoietic stem cell transplantation (HSCT): Best practice consensus guidelines from the British Society for Blood and Marrow Transplant and Cellular Therapies (BSBMTCT), NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group, UK Cancer Genetics Group (UKCGG) and the UK National External Quality Assessment Service for Leucocyte Immunophenotyping (UK NEQAS LI)